Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: CFO Anke Groth verlässt die KION GROUP AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23724/Kion_Group_logo.svg.png
DGAP-News: CFO Anke Groth verlässt die KION GROUP AG
DGAP-News: CFO Anke Groth verlässt die KION GROUP AG
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding successfully completes delisting offer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24110/375px-Hornbach-Holding-AG-Logo.svg.png
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding successfully completes delisting offer
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding successfully completes delisting offer
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding schließt Delisting-Angebot erfolgreich ab : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24110/375px-Hornbach-Holding-AG-Logo.svg.png
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding schließt Delisting-Angebot erfolgreich ab
DGAP-News: HORNBACH Holding AG & Co. KGaA: HORNBACH Holding schließt Delisting-Angebot erfolgreich ab
DGAP-Adhoc: Rheinmetall AG: Rheinmetall increases dividend for fiscal 2021 to EUR 3.30 per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23734/Rheinmetall_AG_Logo.svg.png
DGAP-Adhoc: Rheinmetall AG: Rheinmetall increases dividend for fiscal 2021 to EUR 3.30 per share
DGAP-Adhoc: Rheinmetall AG: Rheinmetall increases dividend for fiscal 2021 to EUR 3.30 per share
DGAP-Adhoc: Rheinmetall AG: Rheinmetall erhöht Dividende für 2021 auf 3,30 EUR je Aktie: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23734/Rheinmetall_AG_Logo.svg.png
DGAP-Adhoc: Rheinmetall AG: Rheinmetall erhöht Dividende für 2021 auf 3,30 EUR je Aktie
DGAP-Adhoc: Rheinmetall AG: Rheinmetall erhöht Dividende für 2021 auf 3,30 EUR je Aktie
DGAP-News: HELLA GmbH & Co. KGaA: Personnel changes in the HELLA Management Board: Michel Favre becomes Chief Executive Officer, Yves Andres takes over the Lighting Business Group: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
DGAP-News: HELLA GmbH & Co. KGaA: Personnel changes in the HELLA Management Board: Michel Favre becomes Chief Executive Officer, Yves Andres takes over the Lighting Business Group
DGAP-News: HELLA GmbH & Co. KGaA: Personnel changes in the HELLA Management Board: Michel Favre becomes Chief Executive Officer, Yves Andres takes over the Lighting Business Group
DGAP-News: HELLA GmbH & Co. KGaA: Veränderungen in der HELLA Geschäftsführung: Michel Favre wird Chief Executive Officer, Yves Andres übernimmt die Business Group Lighting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
DGAP-News: HELLA GmbH & Co. KGaA: Veränderungen in der HELLA Geschäftsführung: Michel Favre wird Chief Executive Officer, Yves Andres übernimmt die Business Group Lighting
DGAP-News: HELLA GmbH & Co. KGaA: Veränderungen in der HELLA Geschäftsführung: Michel Favre wird Chief Executive Officer, Yves Andres übernimmt die Business Group Lighting
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre wird ab dem 1. Juli 2022 Nachfolger des Vorsitzenden der Geschäftsführung (CEO) Dr. Rolf Breidenbach: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre wird ab dem 1. Juli 2022 Nachfolger des Vorsitzenden der Geschäftsführung (CEO) Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre wird ab dem 1. Juli 2022 Nachfolger des Vorsitzenden der Geschäftsführung (CEO) Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre will succeed Chief Executive Officer (CEO) Dr. Rolf Breidenbach as of July 1, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre will succeed Chief Executive Officer (CEO) Dr. Rolf Breidenbach as of July 1, 2022
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Michel Favre will succeed Chief Executive Officer (CEO) Dr. Rolf Breidenbach as of July 1, 2022
Notice of ABB’s Annual General Meeting on March 24, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
Notice of ABB’s Annual General Meeting on March 24, 2022


ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 24, 2022. The invitation can be found attached and at www.abb.com/agm.


This press

Notice of ABB’s Annual General Meeting on March 24, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
Notice of ABB’s Annual General Meeting on March 24, 2022


ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 24, 2022. The invitation can be found attached and at www.abb.com/agm.


This press

ABB Publishes 2021 Annual Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
ABB Publishes 2021 Annual Report


Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange



ABB Ltd published its 2021 annual report and filed the annual report on Form 20-F with the United States Securities and

ABB Publishes 2021 Annual Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
ABB Publishes 2021 Annual Report


Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange



ABB Ltd published its 2021 annual report and filed the annual report on Form 20-F with the United States Securities and

Swiss Re erzielt 2021 Gewinn von 1,4 Mrd. USD und gibt ehrgeizige neue Finanzziele bekannt: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23982/Swiss_Re_2013_logo.svg.png
Swiss Re erzielt 2021 Gewinn von 1,4 Mrd. USD und gibt ehrgeizige neue Finanzziele bekannt
Swiss Re erzielt 2021 Gewinn von 1,4 Mrd. USD und gibt ehrgeizige neue Finanzziele bekannt
Swiss Re reports net income of USD 1.4 billion for 2021 and announces ambitious new financial targets: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23982/Swiss_Re_2013_logo.svg.png
Swiss Re reports net income of USD 1.4 billion for 2021 and announces ambitious new financial targets
Swiss Re reports net income of USD 1.4 billion for 2021 and announces ambitious new financial targets
Record Results, Strategy 2022 Achieved One Year In Advance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png
Record Results, Strategy 2022 Achieved One Year In Advance
Record Results, Strategy 2022 Achieved One Year In Advance
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt
Record Results, Strategy 2022 Achieved One Year In Advance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png
Record Results, Strategy 2022 Achieved One Year In Advance
Record Results, Strategy 2022 Achieved One Year In Advance
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23785/LafargeHolcim_logo.png
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt
Holcim mit Rekordergebnissen, Strategie 2022 ein Jahr im Voraus umgesetzt
EQS-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
EQS-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
EQS-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study

Gap Inc. Announces Plan to Increase Dividend by 25 Percent: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24465/225px-Gap_logo.svg.png
Gap Inc. Announces Plan to Increase Dividend by 25 Percent


Gap Inc. (NYSE: GPS) today announced its board of directors approved plans to increase the company’s annual dividend per share to $0.60 in fiscal year 2022, a 25 percent increase from the company’s

Essex Announces Its 28th Consecutive Annual Dividend Increase: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg
Essex Announces Its 28th Consecutive Annual Dividend Increase


Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has approved a 5.3% increase to its annual cash dividend. This represents the 28th consecutive annual dividend

Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights: https://mms.businesswire.com/media/20191101005100/en/736004/5/Sangamo_logoTM.jpg
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported fourth quarter and full year 2021 financial results and recent business highlights.



“In 2021, we continued

Upland Software Reports Fourth Quarter and Full Year 2021 Financial Results and Announces Acquisition of BA Insight: https://mms.businesswire.com/media/20191107006065/en/707094/5/Upland-Blue-cmyk.jpg
Upland Software Reports Fourth Quarter and Full Year 2021 Financial Results and Announces Acquisition of BA Insight


Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the fourth quarter and full year of 2021 and